Programable Albumin-Hitchhiking Nanobodies Enhance the Delivery of STING Agonists to Potentiate Cancer Immunotherapy.
Wilson J, Kimmel B, Arora K, Chada N, Bharti V, Kwiatkowski A, Finklestein J, Hanna A, Arner E, Sheehy T, Pastora L, Yang J, Pagendarm H, Stone P, Taylor B, Hubert L, Gibson-Corley K, May J, McLean J, Rathmell J, Richmond A, Rathmell W, Balko J, Fingleton B, Hargrove-Wiley E.
Wilson J, et al. Among authors: hubert l.
Res Sq [Preprint]. 2024 May 8:rs.3.rs-3243545. doi: 10.21203/rs.3.rs-3243545/v1.
Res Sq. 2024.
PMID: 38766114
Free PMC article.
Preprint.